- Home
- NRT vs RPTX Comparison
NRT vs RPTX Comparison
Compare NRT & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRT
- RPTX
- Stock Information
- Founded
- NRT 1975
- RPTX 2016
- Country
- NRT United States
- RPTX Canada
- Employees
- NRT N/A
- RPTX N/A
- Industry
- NRT Oil & Gas Production
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- NRT Energy
- RPTX Health Care
- Exchange
- NRT Nasdaq
- RPTX Nasdaq
- Market Cap
- NRT 43.1M
- RPTX 58.8M
- IPO Year
- NRT N/A
- RPTX 2020
- Fundamental
- Price
- NRT $5.08
- RPTX $1.37
- Analyst Decision
- NRT
- RPTX Strong Buy
- Analyst Count
- NRT 0
- RPTX 3
- Target Price
- NRT N/A
- RPTX $4.50
- AVG Volume (30 Days)
- NRT 42.3K
- RPTX 190.7K
- Earning Date
- NRT 05-30-2025
- RPTX 05-13-2025
- Dividend Yield
- NRT 9.25%
- RPTX N/A
- EPS Growth
- NRT N/A
- RPTX N/A
- EPS
- NRT 0.56
- RPTX N/A
- Revenue
- NRT $5,942,748.00
- RPTX $1,073,000.00
- Revenue This Year
- NRT N/A
- RPTX N/A
- Revenue Next Year
- NRT N/A
- RPTX N/A
- P/E Ratio
- NRT $9.04
- RPTX N/A
- Revenue Growth
- NRT N/A
- RPTX N/A
- 52 Week Low
- NRT $3.88
- RPTX $0.89
- 52 Week High
- NRT $7.19
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- NRT 62.64
- RPTX 55.96
- Support Level
- NRT $4.36
- RPTX $1.33
- Resistance Level
- NRT $5.19
- RPTX $1.41
- Average True Range (ATR)
- NRT 0.23
- RPTX 0.07
- MACD
- NRT 0.03
- RPTX -0.01
- Stochastic Oscillator
- NRT 86.75
- RPTX 55.56
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.